Abstract
AimsFrontotemporal lobar degeneration (FTLD) and motor neurone disease are linked by the possession of a hexanucleotide repeat expansion in C9ORF72, and both show neuronal cytoplasmic inclusions within cerebellar and hippocampal neurones which are TDP‐43 negative but immunoreactive for p62 and dipeptide repeat proteins (DPR), these being generated by a non‐ATG RAN translation of the expanded region of the gene.MethodsTwenty‐two cases of FTLD from Newcastle were analysed for an expansion in C9ORF72 by repeat primed PCR and Southern blot. Detailed case note analysis was performed, and blinded retrospective clinical impressions were achieved by review of clinical histories. Sections from all major brain regions were immunostained for TDP‐43, p62 and DPR. The extent of TDP‐43 and DPR pathology in expansion bearers was compared with that in 13 other previously identified cases from the Manchester Brain Bank with established disease.ResultsThree Newcastle patients bearing an expansion in C9ORF72 were identified. These three patients died prematurely, two from bronchopneumonia within 10 months and 3 years of onset, and one from myocardial infarction 3 years after onset. In all three, DPR were plentiful throughout all cerebral cortical regions, hippocampus and cerebellum, but TDP‐43 pathological changes were sparse. The severity of DPR pathological changes in these three patients was similar to that in the Manchester series, although the extent of TDP‐43 pathology was significantly less.ConclusionWidespread accumulation of DPR within nerve cells may occur much earlier than that of TDP‐43 in patients with FTLD bearing expansion in C9ORF72.
Highlights
Frontotemporal lobar degeneration (FTLD) presents with a spectrum of clinical entities [1,2] associated with various patterns of pathological protein accumulation [3]
Most of the early pathological descriptions following the discovery of the chromosome 9 open reading frame 72 (C9ORF72) mutation indicated that the associated TDP-43 pathology was usually type B, characterized by neuronal cytoplasmic inclusions (NCI) in all cortical layers but with relatively few dystrophic neurites or neuronal intranuclear inclusions [7,8,9,15]
We have investigated 22 patients from the Newcastle cohort with pathologically confirmed FTLD-TDP, and have detected three patients bearing a hexanucleotide repeat expansion in C9ORF72
Summary
Frontotemporal lobar degeneration (FTLD) presents with a spectrum of clinical entities [1,2] associated with various patterns of pathological protein accumulation [3]. A pathological accumulation of p62 protein, as neuronal cytoplasmic inclusions (NCI), within granule cells of the cerebellum, and CA4 neurones of the hippocampus has been claimed to be a distinctive histological feature of this particular genetic form of FTLD [7,8,9]. Most of the early pathological descriptions following the discovery of the C9ORF72 mutation indicated that the associated TDP-43 pathology was usually type B, characterized by NCI in all cortical layers but with relatively few dystrophic neurites or neuronal intranuclear inclusions [7,8,9,15]. All cases bearing expansions appear to show a similar and characteristic DPR pathology irrespective of what TDP-43 histological type may be present [13,14]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have